Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride

EU orphan designation number: EU/3/13/1122   
Active ingredient: R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Vudbenk Life Science Kft.
Táncsics Mihály utca 18., 5900 Orosháza, Magyarország.

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/05/2013 Orphan designation EMA/OD/183/12 (2013)2559 of 26/04/2013
11/07/2014 Change of name and/or address of sponsor
04/10/2016 Transfer of orphan designation EMA/OD/183/12/T/01 (2016)6425 of 29/09/2016